Lower Urinary Tract Symptoms: What's New in Medical Treatment?
Peyronnet, Benoit
Lower Urinary Tract Symptoms: What's New in Medical Treatment? [electronic resource] - European urology focus 01 2018 - 17-24 p. digital
Publication Type: Journal Article; Review
2405-4569
10.1016/j.euf.2018.04.005 doi
Acetanilides--therapeutic use
Adrenergic beta-3 Receptor Agonists--therapeutic use
Antidiuretic Agents--therapeutic use
Botulinum Toxins, Type A--administration & dosage
Clinical Trials, Phase III as Topic
Deamino Arginine Vasopressin--therapeutic use
Female
Humans
Lower Urinary Tract Symptoms--drug therapy
Male
Models, Animal
Nocturia--drug therapy
Phosphodiesterase 5 Inhibitors--therapeutic use
Prospective Studies
Prostatic Hyperplasia--diagnosis
Randomized Controlled Trials as Topic
Receptors, Vasopressin--agonists
Retrospective Studies
Thiazoles--therapeutic use
Urinary Bladder--drug effects
Urinary Bladder, Overactive--drug therapy
Lower Urinary Tract Symptoms: What's New in Medical Treatment? [electronic resource] - European urology focus 01 2018 - 17-24 p. digital
Publication Type: Journal Article; Review
2405-4569
10.1016/j.euf.2018.04.005 doi
Acetanilides--therapeutic use
Adrenergic beta-3 Receptor Agonists--therapeutic use
Antidiuretic Agents--therapeutic use
Botulinum Toxins, Type A--administration & dosage
Clinical Trials, Phase III as Topic
Deamino Arginine Vasopressin--therapeutic use
Female
Humans
Lower Urinary Tract Symptoms--drug therapy
Male
Models, Animal
Nocturia--drug therapy
Phosphodiesterase 5 Inhibitors--therapeutic use
Prospective Studies
Prostatic Hyperplasia--diagnosis
Randomized Controlled Trials as Topic
Receptors, Vasopressin--agonists
Retrospective Studies
Thiazoles--therapeutic use
Urinary Bladder--drug effects
Urinary Bladder, Overactive--drug therapy